Factor VIII activity in normal volunteers receiving oral thyroid hormone

Area of Science:

• Endocrinology
• Hematology

Background:

• Plasma factor VIII levels are known to be elevated in hyperthyroidism.
• Understanding the mechanisms regulating factor VIII is crucial for cardiovascular and hemostatic health.

Purpose of the Study:

• To investigate the effects of oral thyroid hormone administration on factor VIII levels in healthy males.
• To determine if beta-adrenergic blockade influences thyroid hormone-induced changes in factor VIII.

Main Methods:

• 14 healthy male volunteers received oral levothyroxine; 9 received oral liothyronine.
• Resting pulse and factor VIII-related activities (coagulant activity, antigen, ristocetin co-factor) were measured.
• Beta-adrenergic blockade was administered, and its effects on pulse and factor VIII were assessed.

Main Results:

• Oral levothyroxine and liothyronine significantly increased resting pulse and factor VIII-related activities.
• Beta-adrenergic blockade attenuated the increase in resting pulse.
• Beta-adrenergic blockade did not prevent the elevations in factor VIII-related properties.

Conclusions:

• Thyroid hormones directly influence plasma factor VIII levels, leading to increased coagulant activity, antigen, and ristocetin co-factor activity.
• Beta-adrenergic blockade does not counteract the pro-coagulant effects of thyroid hormones.
• These findings suggest specific regulatory mechanisms linking thyroid function to factor VIII levels.